Literature DB >> 23528903

Dermatofibrosarcoma protuberans in an adolescent: a case report and review of the literature.

Ausilia M Manganoni1, Laura Pavoni, Giulio Gualdi, Daniela Marocolo, Mariella Chiudinelli, Elena Sereni, Camillo Farisoglio, Piergiacomo Calzavara-Pinton.   

Abstract

Classically, dermatofibrosarcoma protuberans (DFSP) is a disease of adults. The world literature revision shows that several pediatric cases have been reported so far; this might suggest that the number of infants with the condition might be larger than that estimated previously. Here, we report the 183rd case of histologically confirmed DFSP in young age. A 14-year-old white male patient came under our care for a slowly growing, pale brownish lesion on the neck skin. A biopsy specimen showed a DFSP. Subsequently, a wide surgery excision with 3 cm of resection margins including the underlying fascia was performed. To date, the patient has been in follow-up for 6 years without evidence of recurrent disease. The clinical features and treatment of DFSP diagnosed in childhood and adolescence reported in the published literature are reviewed to provide new insights about this rare entity. The aim is to emphasize the importance of biopsy for histologic evaluation in the cases that show a persistent or a large cutaneous plaque or nodule without pathognomonic clinical features that permit a clinical diagnosis. An accurate knowledge of the disease is the prerequisite for a wider recognition and appropriate treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23528903     DOI: 10.1097/MPH.0b013e3182843edc

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Palpebral Conjunctival and Tarsal Stromal Tumor.

Authors:  Jae Yong Park; Seong Woo Lee; Je Hyung Hwang; Hyun Jung Kim; Jin Choi
Journal:  Korean J Ophthalmol       Date:  2019-02

Review 2.  Dermatofibrosarcoma protuberans: from translocation to targeted therapy.

Authors:  Jonathan Noujaim; Khin Thway; Cyril Fisher; Robin L Jones
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.